The RE-DUAL PCI (2017) trial found dual therapy with dabigatran and clopidogrel or ticagrelor had lower rates of bleeding and no difference in MACE or stent ...

Overviews of 145 randomised trials of "prolonged" antiplatelet therapy versus control and 29 randomised comparisons between such antiplatelet regimens.

6 мар. 2023 г. · The RE-DUAL PCI (2017) trial found dual therapy with dabigatran and clopidogrel or ticagrelor had lower rates of bleeding and no difference in ...

The focus of this review is the various drug groups that decrease platelet aggregation, and may have a beneficial role in the treatment of acute coronary ...

28 авг. 2021 г. · Randomized trials have established the superiority of drug-eluting stents over bare-metal stents in patients at high bleeding risk receiving 1 ...

31 авг. 2024 г. · Dual antiplatelet therapy (DAPT) for 12 months is the standard of care after coronary stenting in patients with acute coronary syndrome (ACS).

This article reviews current guidelines and evidence on oral antiplatelet therapy after percutaneous coronary intervention, discussing strategies focused on ...

2 мар. 2022 г. · The effectiveness of clopidogrel monotherapy after 1 to 2 months of DAPT is inconclusive, and further investigation is needed to define the optimal therapy.

27 дек. 2023 г. · Combined clopidogrel–aspirin therapy initiated within 72 hours after stroke onset led to a lower risk of new stroke at 90 days than aspirin therapy alone.

31 авг. 2024 г. · Dual antiplatelet therapy (DAPT) for 12 months is the standard of care after coronary stenting in patients with acute coronary syndrome ...